Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Parabilis Medicines has raised $75.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Parabilis Medicines's investors include General Catalyst, RA Capital Management, ARCH Venture Partners, Janus Henderson Investors, Catalio Capital Management.
Parabilis Medicines is headquartered in Cambridge, United States.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Parabilis Medicines is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Parabilis Medicines — Funding & Investors." VCBacked, June 11, 2026, https://www.vcbacked.co/company/parabilis-medicines. Accessed September 1, 2026.
VCBacked. (2026). Parabilis Medicines — Funding & Investors. Retrieved September 1, 2026, from https://www.vcbacked.co/company/parabilis-medicines
{{cite web |title=Parabilis Medicines — Funding & Investors |url=https://www.vcbacked.co/company/parabilis-medicines |website=VCBacked |access-date=September 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated